Stayble Therapeutics

Developing lactic acid based intradiscal injectible formulation for chronic low back pain (cLBP)

placeGothenburg, Vastra Gotaland County, Sweden calendar_todayFounded 2012 groups3 employees language staybletherapeutics.com

Innovation

4 patent families (4 granted) — focus: Human necessities; filing pace steady. Cited 109 times.

YearFilings
20151
20162
20173
20183
20193
20203
20212
20221
20232
20241
20252
20261

Social engagement

Social engagement: 1K social following, 1 post in the last 12 months — above the industry median.

Investor mix

5 investors on record; lead investors include Chalmers Ventures, Almi Invest.

Investor typeCountShare
Venture capital240%
Accelerator & incubator240%
Other / undisclosed120%

Recent activity

18 Nov 2025
Event
Webcast on Q3 report and recent developments
Coming soon